贝利木单抗; 贝利尤单抗
Belimumab (Synonyms: LymphoStat B; Anti-TNFSF13B / BAFF / CD257)
ChemLeader
Catalog No:
CAS No.:
MDLNo:
Formula:
MW:
Size
Quantity
- +
Product Overview
Product Name Belimumab (Synonyms: LymphoStat B; Anti-TNFSF13B / BAFF / CD257)
CAS356547-88-1
MW144.54 kDa
Security information
Product details

Belimumab (LymphoStat B) is a humanized IgG1λ monoclonal antibody against B-lymphocyte stimulator (BLyS) protein. Belimumab antagonizes BLyS activity in autoimmune diseases and B-lymphocyte malignancies. Belimumab can be used for systemic lupus erythematosus (SLE) research.

Related literature
Related
Sorry, no related items
History
Efmoroctocog alfa; Efmoroctocog Alfa
Belimumab (Synonyms: LymphoStat B; Anti-TNFSF13B / BAFF / CD257)
Atorolimumab
Lampalizumab (Anti-Complement Factor D)
Anti-Human CD3xGPRC5D Bispecific Antibody ( Talquetamab; JNJ-64407564; JNJ-7564)
Sibeprenlimab (Synonyms: VIS649)
(R)-Sulforaphane (Synonyms: L-Sulforaphane; (R)-1-Isothiocyanato-4-(methylsulfinyl)butane; 4-Methylsulfinylbutyl isothiocyanate)
Vantictumab (Anti-FZD)
Donanemab
Tarextumab (Anti-NOTCH3)